Xiuping Liu

26.8k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Xiuping Liu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Xiuping Liu has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xiuping Liu's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (5 papers). Xiuping Liu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (5 papers). Xiuping Liu collaborates with scholars based in China, United States and Netherlands. Xiuping Liu's co-authors include Chang‐Gong Liu, Daniel Medina, Hua Zhu, Hao Wu, Jinming Yang, Brad R. Evans, Manuela Ferracin, Thomas J. Kipps, George A. Calin and Rami I. Aqeilan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Xiuping Liu

22 papers receiving 1.5k citations

Hit Papers

MiR-15a and miR-16-1 cluster functions in human leukemia 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuping Liu China 12 1.2k 1.0k 188 130 91 24 1.5k
Yanni Ma China 24 1.3k 1.1× 1.1k 1.0× 136 0.7× 137 1.1× 85 0.9× 52 1.6k
Antonis Giannakakis Greece 14 1.5k 1.3× 1.2k 1.2× 158 0.8× 112 0.9× 35 0.4× 27 1.8k
Huiwen Yan China 15 870 0.7× 553 0.5× 196 1.0× 140 1.1× 33 0.4× 24 1.2k
Chengfei Jiang China 21 880 0.8× 707 0.7× 168 0.9× 87 0.7× 54 0.6× 46 1.2k
Shuang Han China 16 793 0.7× 589 0.6× 239 1.3× 70 0.5× 33 0.4× 21 1.1k
Kwan Yeung Wong Hong Kong 23 1.0k 0.9× 812 0.8× 151 0.8× 105 0.8× 90 1.0× 37 1.4k
Xue‐Qun Luo China 21 1.2k 1.0× 881 0.8× 119 0.6× 105 0.8× 46 0.5× 59 1.5k
Nan Zhao China 24 959 0.8× 672 0.6× 284 1.5× 112 0.9× 28 0.3× 49 1.3k
Meryem Gülfem Öner Germany 7 816 0.7× 766 0.7× 296 1.6× 188 1.4× 25 0.3× 7 1.3k
Yojiro Kotake Japan 19 1.2k 1.0× 619 0.6× 312 1.7× 86 0.7× 20 0.2× 38 1.4k

Countries citing papers authored by Xiuping Liu

Since Specialization
Citations

This map shows the geographic impact of Xiuping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuping Liu more than expected).

Fields of papers citing papers by Xiuping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuping Liu. The network helps show where Xiuping Liu may publish in the future.

Co-authorship network of co-authors of Xiuping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuping Liu. A scholar is included among the top collaborators of Xiuping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuping Liu. Xiuping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Bing, Hui Zhang, Xiuping Liu, Qin Dong, & Hengchang Zang. (2025). Study of glycated human serum albumin in non-enzymatic glycation process based on MIR/NIR spectroscopy. Journal of Molecular Structure. 1335. 141928–141928. 1 indexed citations
3.
Liu, Sihao, Yubin Yu, Qinghua Liu, et al.. (2025). Ubiquitin-editing enzyme A20 protects the inflammatory injury of human corneal epithelial cells against lipoteichoic acid. Cellular Signalling. 134. 111962–111962.
4.
Xu, Shuang, et al.. (2025). Preservation of Beef with Limonene-Rich Citrus Peel Extracts: Antioxidant, Antimicrobial and Textural Benefits. Foods. 14(20). 3506–3506. 1 indexed citations
5.
Yang, Ju Dong, et al.. (2024). Calmodulin 2 expression is associated with poor prognosis in breast cancer. Pathology - Research and Practice. 258. 155326–155326. 2 indexed citations
6.
Zhang, Chenyang, Xiuping Liu, Yong Yang, et al.. (2024). Single-cell profiling and functional screening reveal crucial roles for lncRNAs in the epidermal re-epithelialization of human acute wounds. Frontiers in Surgery. 11. 1349135–1349135. 1 indexed citations
7.
Yu, Yubin, et al.. (2023). A20 functions as a negative regulator of the lipopolysaccharide-induced inflammation in corneal epithelial cells. Experimental Eye Research. 228. 109392–109392. 5 indexed citations
9.
Wu, Jingbo, Xiaojing Li, Hui Liu, & Xiuping Liu. (2023). Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer. Biomedical Reports. 19(1). 50–50. 1 indexed citations
10.
Deng, Bin, Xiuping Liu, & Xiong Wang. (2021). Prognostic and Immunological Role of THBS2 in Colorectal cancer. BioMed Research International. 2021(1). 1124985–1124985. 14 indexed citations
11.
Liu, Xiuping, et al.. (2021). Natural lactucopicrin alleviates importin-α3-mediated NF-κB activation in inflammated endothelial cells and improves sepsis in mice. Biochemical Pharmacology. 186. 114501–114501. 13 indexed citations
12.
Ren, Kehan, Meili Wang, Jigang Wang, et al.. (2020). Long non‐coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR‐345‐5p/RACGAP1‐mediated mitochondrial fission. Molecular Oncology. 15(2). 543–559. 26 indexed citations
14.
Tan, Xiaochao, Priyam Banerjee, Xin Liu, et al.. (2018). The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. Journal of Clinical Investigation. 128(4). 1267–1282. 58 indexed citations
15.
Liu, Runhua, Cong Liu, Dongquan Chen, et al.. (2015). FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells. Cancer Research. 75(8). 1703–1713. 111 indexed citations
16.
Gupta, Manveen K., Carmel Halley, Zhong-Hui Duan, et al.. (2013). miRNA-548c: A specific signature in circulating PBMCs from dilated cardiomyopathy patients. Journal of Molecular and Cellular Cardiology. 62. 131–141. 42 indexed citations
17.
Kim, Yon Hui, Han Liang, Xiuping Liu, et al.. (2012). AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer. Cancer Research. 72(10). 2512–2521. 79 indexed citations
18.
Meng, Fanyin, Shannon Glaser, Heather Francis, et al.. (2011). Functional analysis of microRNAs in human hepatocellular cancer stem cells. Journal of Cellular and Molecular Medicine. 16(1). 160–173. 108 indexed citations
19.
Zhu, Hua, Hao Wu, Xiuping Liu, et al.. (2008). Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochemical Pharmacology. 76(5). 582–588. 369 indexed citations
20.
Calin, George A., Amelia Cimmino, Muller Fabbri, et al.. (2008). MiR-15a and miR-16-1 cluster functions in human leukemia. Proceedings of the National Academy of Sciences. 105(13). 5166–5171. 607 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026